Dr. Andrew Campbell's distinguished training and career path began at Morehouse College. He continued medical school at Case Western Reserve University and completed post graduate training at Massachusetts General Hospital (Harvard) and Lurie Children's Hospital (Northwestern University)  and is currently Director of the Comprehensive Sickle Cell Program @ Children's National Hospital and Associate Professor of Pediatrics @ George Washington University School of Medicine and Health Sciences. Prior to joining Children’s National, Dr. Campbell was Director of the Comprehensive Sickle Cell Center at the University of Michigan, a position he held since 2005.  As an international expert, has lectured regionally, nationally, and globally on issues related to to the care and healthcare system approach to patients and families dealing with the effects of SCD.. He has participated in numerous advocacy efforts for SCD patients and their families  which included assisting with Sickle Cell Disease legislation (Sickle Cell Disease Treatment Centers Act of 2022 and the Sickle Cell Care Expansion Act of 2022),and presenting at a White House Sickle Cell Awareness meeting. Most recently, he has partnered with American Society of Gene and Cell and Gene Therapy help with their sickle cell disease legislative efforts on  Capitol Hill including Congressional and Senate Briefings to support  SCD patients  access to these important curative gene therapies. Dr. Campbell is currently the Principal Investigator of the American Society of Hematology Research Collaborative, “Washington DC, Maryland, Virginia (DMV) Sickle Cell Clinical Trials Network”. For the past several years he has focused his research on the clinical complexity of Sickle CellDisease (SCD) in different populations through a multinational international consortium (CASiRe - Consortium for the Advancement of Sickle Cell Disease Research) which he directs including participants from Ghana, Italy, United Kingdom, and the United States. Other international work includes being a member of the Sickle in Africa Research Consortia, where he serves as a contributor to the SCD Ontology working group.